ArticleScientific reports2025
Global, regional, and national burden of ischemic heart disease in young and middle-aged population from 1990 to 2021.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Changing Trends in Cardiovascular Disease Burden in North Africa and the Middle East, 1990-2023: A Joinpoint Analysis of GBD 2023 Data.Journal of clinical medicine · 2026Article
- Per- and Polyfluoroalkyl Substances Exposure and Ischemic Heart Disease: Emerging Evidence from the Literature.Antioxidants (Basel, Switzerland) · 2026Review
- Article
- The Coronary Venous System in Acute Coronary Syndrome: A Narrative Review.Biomedicines · 2026Review
- Association of low body mass index with the risk of major adverse cardiovascular events among patients with acute myocardial infarction: a single-center cohort study from Iran.BMC cardiovascular disorders · 2026Article
- Preventable mortality in Mexico: bridging gaps in chronic disease and ageing care.BMJ global health · 2026Review
- Ischemic Heart Disease and the Epidemiologic Transition: Progress without Reduction in Global Burden.Discoveries (Craiova, Romania)Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Early-onset ischemic heart disease (IHD) is an emerging global health concern. Quantifying its burden and key risk factors is essential for effective prevention and control. This study utilizes the data from Global Burden of Disease Study 2021 to analyze the burden of IHD in young and middle-aged population (15-49 years old), including prevalence, incidence, deaths and disability-adjusted life years (DALYs) from 1990 to 2021. Attributable risk factors were assessed across different sex and region, and trends were analyzed using age-standardized rate (ASR) and average annual percentage change (AAPC). In 2021, the ASR of prevalence and incidence showed an increasing trend, with AAPCs of 0.26% (95% confidence interval [CI], 0.24% to 0.29%) and 0.23% (95%CI, 0.09% to 0.38%), respectively; the ASR of mortality and DALYs showed a decreasing trend, with AAPCs of -0.67 (95%CI, -0.91% to -0.44%) and - 0.64 (95%CI, -0.87% to -0.42%).The highest burden were observed in countries with low-middle socio-demographic index. Gender differences were observed, with men generally bearing a higher burden. Dietary risks were identified as the most significant risk factors. The burden of early-onset IHD remains a major health challenge, with significant region and gender disparities. The burden needs to be addressed through targeted public health policies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.